Photobiomodulation for Alzheimer's Disease: Has the Light Dawned?

Overview

Journal Photonics

Date 2019 Aug 1

PMID 31363464

Citations 53

Authors

Michael R Hamblin

Affiliations

Soon will be listed here.

Abstract

Next to cancer, Alzheimer's disease (AD) and dementia is probably the most worrying health problem facing the Western world today. A large number of clinical trials have failed to show any benefit of the tested drugs in stabilizing or reversing the steady decline in cognitive function that is suffered by dementia patients. Although the pathological features of AD consisting of beta-amyloid plaques and tau tangles are well established, considerable debate exists concerning the genetic or lifestyle factors that predispose individuals to developing dementia. Photobiomodulation (PBM) describes the therapeutic use of red or near-infrared light to stimulate healing, relieve pain and inflammation, and prevent tissue from dying. In recent years PBM has been applied for a diverse range of brain disorders, frequently applied in a non-invasive manner by shining light on the head (transcranial PBM). The present review discusses the mechanisms of action of tPBM in the brain, and summarizes studies that have used tPBM to treat animal models of AD. The results of a limited number of clinical trials that have used tPBM to treat patients with AD and dementia are discussed.

Citing Articles

810-nm Photobiomodulation Evokes Glutamate Release in Normal and Rotenone-Dysfunctional Cortical Nerve Terminals by Modulating Mitochondrial Energy Metabolism.

Ravera S, Farsetti E, Maura G, Marcoli M, Bozzo M, Cervetto C Cells. 2025; 14(2).

PMID: 39851493 PMC: 11764165. DOI: 10.3390/cells14020067.

40 Hz light preserves synaptic plasticity and mitochondrial function in Alzheimer's disease model.

Behrooz A, Aghanoori M, Nazari M, Latifi-Navid H, Vosoughian F, Anjomani M Sci Rep. 2024; 14(1):26949.

PMID: 39506052 PMC: 11541745. DOI: 10.1038/s41598-024-78528-7.

Editorial: Photobiomodulation therapy for brain disorders.

Wu C, Wu T, Yang L Front Neurol. 2024; 15:1495715.

PMID: 39391166 PMC: 11464434. DOI: 10.3389/fneur.2024.1495715.

Can infrared light really be doing what we claim it is doing? Infrared light penetration principles, practices, and limitations.

Henderson T Front Neurol. 2024; 15:1398894.

PMID: 39263274 PMC: 11388112. DOI: 10.3389/fneur.2024.1398894.

Modifying Alzheimer's disease pathophysiology with photobiomodulation: model, evidence, and future with EEG-guided intervention.

Lim L Front Neurol. 2024; 15:1407785.

PMID: 39246604 PMC: 11377238. DOI: 10.3389/fneur.2024.1407785.

References

Yang Y, Gao L . Celecoxib Alleviates Memory Deficits by Downregulation of COX-2 Expression and Upregulation of the BDNF-TrkB Signaling Pathway in a Diabetic Rat Model. J Mol Neurosci. 2017; 62(2):188-198. PMC: 5486519. DOI: 10.1007/s12031-017-0922-0. View

Lim W, Kim J, Kim S, Karna S, Won J, Jeon S . Modulation of lipopolysaccharide-induced NF-κB signaling pathway by 635 nm irradiation via heat shock protein 27 in human gingival fibroblast cells. Photochem Photobiol. 2012; 89(1):199-207. DOI: 10.1111/j.1751-1097.2012.01225.x. View

Orihuela R, McPherson C, Harry G . Microglial M1/M2 polarization and metabolic states. Br J Pharmacol. 2015; 173(4):649-65. PMC: 4742299. DOI: 10.1111/bph.13139. View

Chen Z, Zhong C . Oxidative stress in Alzheimer's disease. Neurosci Bull. 2014; 30(2):271-81. PMC: 5562667. DOI: 10.1007/s12264-013-1423-y. View

Wu S, Zhou F, Wei Y, Chen W, Chen Q, Xing D . Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst. Antioxid Redox Signal. 2013; 20(5):733-46. PMC: 3910666. DOI: 10.1089/ars.2013.5229. View

Pollack G, Reitz F . Phase transitions and molecular motion in the cell. Cell Mol Biol (Noisy-le-grand). 2001; 47(5):885-900. View

Tang Y, Le W . Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol Neurobiol. 2015; 53(2):1181-1194. DOI: 10.1007/s12035-014-9070-5. View

Ryu J, Yoo S, Kim K, Park J, Bang S, Lee S . Laser modulation of heat and capsaicin receptor TRPV1 leads to thermal antinociception. J Dent Res. 2010; 89(12):1455-60. DOI: 10.1177/0022034510381394. View

Zhang L, Li H, Zeng S, Chen L, Fang Z, Huang Q . Long-term tracing of the BrdU label-retaining cells in adult rat brain. Neurosci Lett. 2015; 591:30-34. DOI: 10.1016/j.neulet.2015.02.023. View

10.

de Freitas L, Hamblin M . Proposed Mechanisms of Photobiomodulation or Low-Level Light Therapy. IEEE J Sel Top Quantum Electron. 2017; 22(3). PMC: 5215870. DOI: 10.1109/JSTQE.2016.2561201. View

11.

Wadsworth T, Bishop J, Pappu A, Woltjer R, Quinn J . Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer's disease. J Alzheimers Dis. 2008; 14(2):225-34. PMC: 2931577. DOI: 10.3233/jad-2008-14210. View

12.

Ritchie C, Terrera G, Quinn T . Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research. Alzheimers Res Ther. 2015; 7(1):31. PMC: 4364079. DOI: 10.1186/s13195-015-0113-6. View

13.

Mungrue I, Husain M, Stewart D . The role of NOS in heart failure: lessons from murine genetic models. Heart Fail Rev. 2002; 7(4):407-22. DOI: 10.1023/a:1020762401408. View

14.

Tuby H, Maltz L, Oron U . Induction of autologous mesenchymal stem cells in the bone marrow by low-level laser therapy has profound beneficial effects on the infarcted rat heart. Lasers Surg Med. 2011; 43(5):401-9. DOI: 10.1002/lsm.21063. View

15.

Kisler K, Nelson A, Montagne A, Zlokovic B . Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017; 18(7):419-434. PMC: 5759779. DOI: 10.1038/nrn.2017.48. View

16.

Yan X, Liu J, Zhang Z, Li W, Sun S, Zhao J . Low-level laser irradiation modulates brain-derived neurotrophic factor mRNA transcription through calcium-dependent activation of the ERK/CREB pathway. Lasers Med Sci. 2016; 32(1):169-180. DOI: 10.1007/s10103-016-2099-0. View

17.

Iaccarino H, Singer A, Martorell A, Rudenko A, Gao F, Gillingham T . Gamma frequency entrainment attenuates amyloid load and modifies microglia. Nature. 2016; 540(7632):230-235. PMC: 5656389. DOI: 10.1038/nature20587. View

18.

Mullane K, Williams M . Alzheimer's disease (AD) therapeutics - 1: Repeated clinical failures continue to question the amyloid hypothesis of AD and the current understanding of AD causality. Biochem Pharmacol. 2018; 158:359-375. DOI: 10.1016/j.bcp.2018.09.026. View

19.

Bartos A, Grondin Y, Bortoni M, Ghelfi E, Sepulveda R, Carroll J . Pre-conditioning with near infrared photobiomodulation reduces inflammatory cytokines and markers of oxidative stress in cochlear hair cells. J Biophotonics. 2016; 9(11-12):1125-1135. DOI: 10.1002/jbio.201500209. View

20.

Porta Santos Fernandes K, Souza N, Mesquita-Ferrari R, de Fatima Teixeira da Silva D, Rocha L, Alves A . Photobiomodulation with 660-nm and 780-nm laser on activated J774 macrophage-like cells: Effect on M1 inflammatory markers. J Photochem Photobiol B. 2015; 153:344-51. PMC: 4674369. DOI: 10.1016/j.jphotobiol.2015.10.015. View